leucine has been researched along with Carcinoma, Non-Small Cell Lung in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 7 (41.18) | 2.80 |
| Authors | Studies |
|---|---|
| Kovács, A; Kurucz, I; Lázár, J; Takács, L; Tornyi, I | 1 |
| He, KM; Pu, JT; Teng, ZY; Wu, YF; Zhang, DG; Zhang, T | 1 |
| Liang, L; Wang, X; Yin, W | 1 |
| Dang, K; Li, Y; Liu, L; Wang, X; Xu, H; Xu, X; Yan, X; Zhang, Y | 1 |
| Fan, K; Huang, A; Li, C; Li, J; Wan, L; Xing, S; Zhai, W | 1 |
| Ding, GG; Ling, XA; Wan, J; Wang, J; Wang, X | 1 |
| Hu, X; Huang, S; Mao, T; Su, T; Xiong, H; Yang, L | 1 |
| Lin, R; Ling, YH; Perez-Soler, R | 1 |
| Ito, S; Miyahara, R; Nagai, S; Takahashi, R; Takenaka, K; Tanaka, F; Wada, H | 1 |
| Imai, H; Ishizuka, T; Kaira, K; Kanai, Y; Mori, M; Nagamori, S; Nakajima, T; Oriuchi, N; Promchan, K; Shimizu, K; Sunaga, N; Tominaga, H; Yamamoto, N; Yanagitani, N | 1 |
| Bird, SP; Keogh, JW; MacLeod, RD; Rogers, ES; Stewart, J | 1 |
| Fukuhara, T; Inoue, A; Kimura, Y; Maemondo, M; Morikawa, N; Nukiwa, T; Saijo, Y; Suzuki, T; Watanabe, H | 1 |
| Agulnik, JS; Batist, G; Chong, G; Cohen, V; Jarry, J; Kreisman, H; Miller, WH; Small, D; Tejada, NA | 1 |
| Fukui, T; Furuta, K; Kunitoh, H; Matsuno, Y; Nokihara, H; Ohe, Y; Sakamoto, H; Sekine, I; Takano, T; Tamura, T; Tateishi, U; Tsuta, K; Yamamoto, N; Yoshida, T | 1 |
| Ebert, W; Jülke, B; Lah, T; Spiess, E; Werle, B | 1 |
| Mouritzen, C | 1 |
| Cotelingam, JD; Funa, K; Gazdar, AF; Linnoila, RI; Matthews, MJ; Mulshine, JL; Steinberg, SM | 1 |
1 review(s) available for leucine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Efficacy of Standardised Treatments Combined with Ubenimex in Patients with Malignant Tumors.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Leucine; Lung Neoplasms; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Survival Rate | 2021 |
3 trial(s) available for leucine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), resistance training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients--ACCeRT study.
Topics: Adult; Amino Acids, Essential; Cachexia; Carcinoma, Non-Small-Cell Lung; Celecoxib; Combined Modality Therapy; Cyclooxygenase 2 Inhibitors; Dietary Supplements; Eicosapentaenoic Acid; Feasibility Studies; Female; Humans; Leucine; Lung Neoplasms; Male; Middle Aged; New Zealand; Patient Satisfaction; Prospective Studies; Pyrazoles; Resistance Training; Sulfonamides | 2011 |
Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Antineoplastic Agents; Arginine; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; ErbB Receptors; Feasibility Studies; Female; Gefitinib; Glutamic Acid; Humans; Leucine; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Quinazolines; Treatment Outcome | 2006 |
Bestatin as adjuvant treatment in operated stage I and stage II non-small cell lung cancer. European Lung Cancer Study Group.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Humans; Leucine; Lung Neoplasms; Lymph Nodes; Neoplasm Staging; Survival Analysis | 1990 |
13 other study(ies) available for leucine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Detection of leucine-rich alpha-2-glycoprotein 1 containing immunocomplexes in the plasma of lung cancer patients with epitope-specific mAbs.
Topics: Antibodies, Monoclonal; Autoantibodies; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Enzyme-Linked Immunosorbent Assay; Epitopes; Glycoproteins; Humans; Immunoglobulin G; Leucine; Lung Neoplasms | 2022 |
Transient receptor potential vanilloid 4 promotes the growth of non-small cell lung cancer by regulating Foxp3.
Topics: A549 Cells; Aged; Apoptosis; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Female; Forkhead Transcription Factors; Humans; Leucine; Lung Neoplasms; Male; Middle Aged; Morpholines; Pyrroles; Sulfonamides; TRPV Cation Channels | 2022 |
PELP1 is overexpressed in lung cancer and promotes tumor cell malignancy and resistance to tyrosine kinase inhibitor drug.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Co-Repressor Proteins; CTLA-4 Antigen; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Glutamates; Humans; Leucine; Lung Neoplasms; Proline; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Transcription Factors | 2022 |
Association of plasma branched-chain amino acid with multiple cancers: A mendelian randomization analysis.
Topics: Amino Acids, Branched-Chain; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Genome-Wide Association Study; Humans; Isoleucine; Leucine; Lung Neoplasms; Mendelian Randomization Analysis; Valine | 2023 |
MicroRNA-125a attenuates the chemoresistance against ubenimex in non-small cell lung carcinoma via targeting the aminopeptidase N signaling pathway.
Topics: Antibiotics, Antineoplastic; Apoptosis; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; CD13 Antigens; Cell Cycle; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Leucine; Lung Neoplasms; MicroRNAs; Prognosis; Tumor Cells, Cultured | 2020 |
Inhibitory effect of Ubenimex combined with fluorouracil on multiple drug resistance and P-glycoprotein expression level in non-small lung cancer.
Topics: A549 Cells; Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Non-Small-Cell Lung; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Leucine; Lung Neoplasms; Mice, Inbred C57BL; Mice, Nude; RNA, Messenger | 2020 |
Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK.
Topics: Amino Acid Substitution; Apoptosis; Arginine; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Caspase Inhibitors; Cell Line, Tumor; Down-Regulation; Drug Screening Assays, Antitumor; Enzyme Inhibitors; ErbB Receptors; Erlotinib Hydrochloride; Humans; Leucine; Lung Neoplasms; Mitochondria; Mutation; Oxidative Phosphorylation; Protein Structure, Quaternary; Protein Transport; Quinazolines; Reactive Oxygen Species; RNA, Small Interfering | 2008 |
Stromal aminopeptidase N expression: correlation with angiogenesis in non-small-cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; CD13 Antigens; Chemotherapy, Adjuvant; Female; Fibroblasts; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Leucine; Lung Neoplasms; Lymph Node Excision; Male; Microvessels; Middle Aged; Neovascularization, Pathologic; Pneumonectomy; Retrospective Studies; Time Factors; Treatment Outcome | 2009 |
Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids, Cyclic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Growth Processes; Cell Line, Tumor; ErbB Receptors; Fusion Regulatory Protein-1; Gefitinib; Humans; Immunohistochemistry; Large Neutral Amino Acid-Transporter 1; Leucine; Lung Neoplasms; Middle Aged; Mutation; Quinazolines; RNA, Messenger; TOR Serine-Threonine Kinases | 2010 |
Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer.
Topics: Arginine; Carcinoma, Non-Small-Cell Lung; Chromatography, High Pressure Liquid; DNA Mutational Analysis; ErbB Receptors; Humans; Leucine; Lung Neoplasms; Mutation; Nucleic Acid Denaturation; Sensitivity and Specificity | 2006 |
Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Antineoplastic Agents; Arginine; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; DNA Mutational Analysis; ErbB Receptors; Female; Gefitinib; Humans; Leucine; Lung Neoplasms; Male; Middle Aged; Mutation; Prognosis; Quinazolines; Survival Analysis; Treatment Outcome | 2007 |
Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cathepsin B; Cysteine Proteinase Inhibitors; Dipeptides; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Leucine; Lung; Lung Neoplasms; Middle Aged; Prognosis; Substrate Specificity; Survival Analysis | 1997 |
Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Chromogranin A; Chromogranins; Humans; Leucine; Lung Neoplasms; Phosphopyruvate Hydratase | 1988 |